Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Published Aug 17, 2020

Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Patients and doctors are encouraged that clinical trials have started up again. A leading expert talks to SurvivorNet about why you shouldn't be afraid to consider a clinical trial during the outbreak.

NOW
PLAYING
When is a Stem Cell Transplant the Best Option for a Multiple Myeloma Patient?
NOW
PLAYING
What Are the Various Treatment Options for Multiple Myeloma Induction Therapy?
NOW
PLAYING
Exciting New Immunotherapy Treatments for Multiple Myeloma
NOW
PLAYING
Multiple Myeloma Relapse: Is There a Go-To Treatment?
NOW
PLAYING
Multiple Myeloma — Which Drugs Are Best for Induction Chemotherapy?
NOW
PLAYING
Could Monoclonal Antibody Treatment Be a Game-Changer for People with Weakened Immune Systems? Here's What Cancer Patients Need to Know

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.